Albrecht Wendel

Q: What Schools Are Affiliated With Albrecht Wendel

Albrecht Wendel is affiliated with the following schools: University of Konstanz, University of Tübingen

Albrecht Wendel's AcademicInfluence.com Rankings

Albrecht Wendel

Chemistry

#2730

World Rank

#3679

Historical Rank

chemistry Degrees

Albrecht Wendel

Biology

#7697

World Rank

#10656

Historical Rank

Molecular Biology

#909

World Rank

#932

Historical Rank

Biochemistry

#1069

World Rank

#1184

Historical Rank

biology Degrees

Download Badge

Chemistry
Biology

Albrecht Wendel's Degrees

PhD Biochemistry University of California, Berkeley
Masters Chemistry Stanford University
Bachelors Chemistry Stanford University

Why Is Albrecht Wendel Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Albrecht Wendel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

[44] Glutathione peroxidase (1981) (1070)
A T cell-dependent experimental liver injury in mice inducible by concanavalin A. (1992) (1058)
The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution. (1983) (573)
Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. (1994) (528)
Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. (1995) (526)
Selenium in Biology and Medicine (1989) (378)
A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase. (1984) (373)
Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. (1995) (354)
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. (1989) (308)
Acute paracetamol intoxication of starved mice leads to lipid peroxidation in vivo. (1979) (303)
Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. (1995) (286)
Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha. (1992) (240)
The fate of extracellular glutathione in the rat. (1978) (229)
Drug-induced lipid peroxidation in mice--I. Modulation by monooxygenase activity, glutathione and selenium status. (1981) (207)
In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis (1997) (200)
Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. (1997) (200)
Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. (2000) (188)
Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone. (1993) (188)
International validation of novel pyrogen tests based on human monocytoid cells. (2005) (171)
In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor‐α release by PDE inhibitors (1997) (171)
Functions of Glutathione in Liver and Kidney (1978) (160)
Non-reactivity of the selenoenzyme glutathione peroxidase with enzymatically hydroperoxidized phospholipids. (1983) (159)
The level and half‐life of glutathione in human plasma (1980) (158)
Phospholipid hydroperoxide glutathione peroxidase in various mouse organs during selenium deficiency and repletion. (1990) (149)
ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. (1997) (148)
Structure analysis and molecular model of the selenoenzyme glutathione peroxidase at 2.8 A resolution. (1979) (143)
DNA fragmentation in mouse organs during endotoxic shock. (1996) (140)
Drug-induced lipid peroxidation in mice--II. Protection against paracetamol-induced liver necrosis by intravenous liposomally entrapped glutathione. (1982) (130)
Lipopolysaccharide‐induced interleukin‐10 in mice: role of endogenous tumor necrosis factor‐α (1995) (130)
Improved Innate Immunity of Endotoxin-Tolerant Mice Increases Resistance to Salmonella enterica Serovar Typhimurium Infection despite Attenuated Cytokine Response (2001) (130)
The 55-kD Tumor Necrosis Factor Receptor and CD95 Independently Signal Murine Hepatocyte Apoptosis and Subsequent Liver Failure (1996) (129)
The role of acrolein in allyl alcohol-induced lipid peroxidation and liver cell damage in mice. (1987) (125)
A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. (1985) (120)
The amino-acid sequence of bovine glutathione peroxidase. (1984) (119)
Leukotriene-mediated liver injury. (1988) (118)
Diurnal fluctuation and pharmacological alteration of mouse organ glutathione content. (1985) (108)
Concanavalin A hepatotoxicity in mice: Tumor necrosis factor–mediated organ failure independent of caspase‐3–like protease activation (1999) (107)
Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury (2007) (107)
[Detection of Pyrogens using human whole blood] (1996) (107)
Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice. (1997) (104)
In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor. (1997) (104)
A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice. (1986) (103)
Metabolic Depletion of Atp by Fructose Inversely Controls Cd95- and Tumor Necrosis Factor Receptor 1–Mediated Hepatic Apoptosis (2000) (103)
Chapter 16 – Glutathione Peroxidase (1980) (101)
Interleukin‐1 and nitric oxide protect against tumor necrosis factor α‐induced liver injury through distinct pathways (1995) (101)
Novel Pyrogen Tests Based on the Human Fever Reaction (2001) (98)
Tumor Necrosis Factor-α and Angiostatin Are Mediators of Endothelial Cytotoxicity in Bronchoalveolar Lavages of Patients with Acute Respiratory Distress Syndrome (2002) (89)
Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages (1995) (89)
Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. (1994) (82)
Detection of endotoxins and other pyrogens using human whole blood. (1999) (80)
Substrate-induced redox change of selenium in glutathione peroxidase studied by x-ray photoelectron spectroscopy. (1975) (79)
Cyclic nucleotide phosphodiesterases from purified human CD4+ and CD8+ T lymphocytes (1995) (79)
Protection from T cell-mediated murine liver failure by phosphodiesterase inhibitors. (1997) (77)
Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice. (2000) (76)
Dichotomal Role of TNF in Experimental Pulmonary Edema Reabsorption (2005) (75)
Phosphodiesterase profile of human B lymphocytes from normal and atopic donors and the effects of PDE inhibition on B cell proliferation (1998) (74)
Phosphodiesterase profiles of highly purified human peripheral blood leukocyte populations from normal and atopic individuals: a comparative study. (1997) (73)
Glutathione Dependence of Caspase-8 Activation at the Death-inducing Signaling Complex* (2002) (72)
Reactivity of antiinflammatory and superoxide dismutase active Cu(II)-salicylates. (1978) (72)
The activities of the key enzymes of the γ‐glutamyl cycle in microdissected segments of the rat nephron (1977) (70)
Cryopreservation of human whole blood for pyrogenicity testing. (2004) (69)
Selenium and drug metabolism--I. Multiple modulations of mouse liver enzymes. (1983) (68)
CD95‐mediated murine hepatic apoptosis requires an intact glutathione status (1999) (68)
In vitro pyrogen test for toxic or immunomodulatory drugs. (2006) (67)
The value of alternative testing for neurotoxicity in the context of regulatory needs. (2006) (65)
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions (1999) (64)
Control of fecal peritoneal infection in mice by colony-stimulating factors. (1996) (63)
A novel mechanism of murine hepatocyte death inducible by concanavalin A. (1996) (63)
Toxicity of nutritionally available selenium compounds in primary and transformed hepatocytes. (2004) (62)
Atrial Natriuretic Peptide, a Regulator of Nuclear Factor-κB Activation in Vivo (2007) (62)
NADH-dependent reductive stress and ferritin-bound iron in allyl alcohol-induced lipid peroxidation in vivo: the protective effect of vitamin E. (1992) (62)
GSH rescue by N-acetylcysteine (1991) (61)
Immunoproteomic Identification and Serological Responses to Novel Chlamydia pneumoniae Antigens That Are Associated with Persistent C. pneumoniae Infections1 (2008) (61)
Cytokine-mediated hepatic apoptosis. (1998) (60)
Endogenous cortisol determines the circadian rhythm of lipopolysaccharide‐ but not lipoteichoic acid‐inducible cytokine release (2006) (60)
Novel Advanced In Vitro Methods for Long-term Toxicity Testing (2001) (58)
Endotoxin-inducible cytotoxicity in liver cell cultures--I. (1991) (58)
The short prodomain influences caspase-3 activation in HeLa cells. (2000) (57)
Selenium and drug metabolism--II. Independence of glutathione peroxidase and reversibility of hepatic enzyme modulations in deficient mice. (1984) (54)
Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice. (1987) (54)
Modulation of Cytokine Release in Ex Vivo-Stimulated Blood from Borreliosis Patients (2001) (53)
Drug-induced lipid peroxidation in mice--III. Glutathione content of liver, kidney and spleen after intravenous administration of free and liposomally entrapped glutathione. (1982) (53)
Hepatic microsomal dealkylations. Inhibition by a tyrosine-copper (II) complex provided with superoxide dismutase activity. (1977) (51)
Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice. (1999) (51)
In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. (2001) (50)
Time course of IL-6 and TNFα release during endotoxin-induced endotoxin tolerance in rats (1991) (50)
Cyclooxygenase-2-Dependent Bronchoconstriction in Perfused Rat Lungs Exposed to Endotoxin (1996) (50)
Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice. (1993) (49)
A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation. (2014) (48)
Selenium and drug metabolism--III. Relation of glutathione-peroxidase and other hepatic enzyme modulations to dietary supplements. (1985) (48)
Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury. (1998) (47)
Characterization of the phosphodiesterase (PDE) pattern of in vitro-generated human dendritic cells (DC) and the influence of PDE inhibitors on DC function. (1999) (47)
Chemically-induced glutathione depletion and lipid peroxidation. (1982) (46)
Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. (2002) (46)
[2] Hydrocarbon exhalation (1981) (46)
The Effect of Selenium on Immune Functions of J774.1 Cells (2003) (45)
Measurement of in vivo lipid peroxidation and toxicological significance. (1987) (45)
The lectin-like domain of tumor necrosis factor improves lung function after rat lung transplantation—Potential role for a reduction in reactive oxygen species generation* (2010) (42)
TNF: a moonlighting protein at the interface between cancer and infection. (2008) (41)
A link between extracellular reactive oxygen and endotoxin-induced release of tumour necrosis factor alpha in vivo. (1992) (40)
Kupffer Cell-Expressed Membrane-Bound TNF Mediates Melphalan Hepatotoxicity via Activation of Both TNF Receptors1 (2005) (40)
Studies on the hepatotoxicity of galactosamine/endotoxin or galactosamine/TNF in the perfused mouse liver. (1990) (40)
Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock. (1996) (39)
In vitro pyrogen test--A new test method for solid medical devices. (2007) (38)
In vivo evidence for protease-catalysed mechanism providing bioactive tumor necrosis factor alpha. (1990) (37)
Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF‐mediated apoptosis (2004) (35)
Filgrastim restores interleukin-2 production in blood from patients with advanced human immunodeficiency virus infection. (1998) (35)
Temporal Sequence of Pulmonary and Systemic Inflammatory Responses to Graded Polymicrobial Peritonitis in Mice (1999) (34)
Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice. (1990) (33)
Leukotriene D4 mediates galactosamine/endotoxin-induced hepatitis in mice. (1987) (32)
Selenium- and non-selenium-dependent glutathione peroxidases in mouse liver. (1982) (32)
Ethane production by isolated perfused rat liver: a system to study metabolic effects related to lipid peroxidation. (1981) (31)
Topology and Function of Renal γ-Glutamyl Transpeptidase (1978) (31)
Atrial natriuretic peptide, a regulator of nuclear factor-kappaB activation in vivo. (2007) (29)
Role of granulocyte colony-stimulating factor in infection and inflammation (1998) (29)
Prenylated Stilbenes and Their Novel Biogenetic Derivatives from Artocarpus chama (2006) (29)
Endotoxin‐inducible granulocyte‐mediated hepatocytotoxicity requires adhesion and serine protease release (1996) (29)
The Selenium Moiety of Glutathione Peroxidase (1978) (28)
The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. (2010) (28)
Role of TNF‐α in High‐Dose Antigen Therapy in Experimental Autoimmune Neuritis: Inhibition of TNF‐α by Neutralizing Antibodies Reduces T‐Cell Apoptosis and Prevents Liver Necrosis (2000) (27)
Drug-induced lipid peroxidation in mice--IV. In vitro hydrocarbon evolution, reduction of oxygen and covalent binding of acetaminophen. (1983) (27)
Identification of phosphodiesterase IV activity and its cyclic adenosine monophosphate-dependent up-regulation in a human keratinocyte cell line (HaCaT). (1995) (26)
[74] Biochemical pharmacology of inflammatory liver injury in mice (1990) (25)
Redox control of hepatic cell death. (2003) (25)
Inhibition by ebselen of microsomal NADPH-cytochrome P450-reductase in vitro but not in vivo. (1986) (25)
G-CSF - an anti-inflammatory cytokine (1995) (25)
GM-CSF Restores Innate, But Not Adaptive, Immune Responses in Glucocorticoid-Immunosuppressed Human Blood In Vitro1 (2003) (25)
Manipulation of mouse organ glutathione contents I: Enhancement by oral administration of butylated hydroxyanisole and butylated hydroxytoluene. (1985) (25)
Tumor necrosis factor: how to make a killer molecule tumor-specific? (2005) (23)
The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rats. (1983) (22)
Drug-induced lipid peroxidation in mice--V. Ethane production and glutathione release in the isolated liver upon perfusion with acetaminophen. (1983) (22)
High sensitivity pyrogen testing in water and dialysis solutions. (2008) (21)
Overactivation of the immune system by translocated bacteria and bacterial products. (1997) (21)
Colchicine prevents tumor necrosis factor-induced toxicity in vivo (1992) (20)
Biochemical Functions of Selenium (1992) (20)
[15-Hydroxyprostaglandin dehydrogenase from human placenta. 1. Isolation and characterization]. (1975) (19)
The activity of the peroxide-metabolizing system in human colon carcinoma (2004) (19)
Crystallographic data of the selenoenzyme glutathione peroxidase. (1976) (19)
Endotoxin-inducible cytotoxicity in liver cell cultures--II. Demonstration of endotoxin-tolerance. (1992) (19)
Blood cytokine response of low-dose molgramostim (rhGM-CSF)-treated patients. (2000) (19)
Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines. (1996) (19)
Testing of immunomodulatory properties in vitro. (1996) (19)
Alterations in the intermediary metabolism of selenium-deficient mice. (1987) (18)
A possible role of plasma glutathione in glucose-mediated insulin secretion: in vitro and in vivo studies in rats (1989) (18)
Hepatic uptake and antihepatotoxic properties of vitamin E and liposomes in the mouse. (1990) (17)
Manipulation of mouse organ glutathione contents. II: Time and dose-dependent induction of the glutathione conjugation system by phenolic antioxidants. (1986) (17)
Drug-induced Lipid Peroxidation in Mouse Liver (1978) (17)
Biochemical pharmacology of inflammatory liver injury in mice. (1990) (16)
Time course of IL-6 and TNF alpha release during endotoxin-induced endotoxin tolerance in rats. (1991) (15)
Inhibition by superoxide dismutase of linoleic acid peroxidation induced by lipoxidase (1975) (15)
Chapter 16 – Metabolism of Organic Hydroperoxides (1982) (15)
ATP-Depleting Carbohydrates Prevent Tumor Necrosis Factor Receptor 1-Dependent Apoptotic and Necrotic Liver Injury in Mice (2007) (15)
Ebselen Improves Ischemia-Reperfusion Injury After Rat Lung Transplantation (2009) (15)
The degradation of glutathione derivatives in the rat kidney. (1977) (14)
Binding of paracetamol metabolites to mouse liver glutathione S-transferases. (1981) (14)
[Glutathion peroxidase. I. Isolation and determinations of molecular weight]. (1971) (13)
The effect of a tyrosine‐divalent copper complex on hepatic microsomal demethylation (1976) (13)
Choleresis and increased biliary efflux of glutathione induced by phenolic antioxidants in rats. (1988) (13)
Alterations in the protein-synthesis, -degradation and/or -secretion rates in hepatic subcellular fractions of selenium-deficient mice. (1989) (13)
Disposition and hepatoprotection by phosphatidyl choline liposomes in mouse liver. (1987) (12)
Tunicamycin potently inhibits tumor necrosis factor-induced hepatocyte apoptosis. (1995) (12)
Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis. (2000) (11)
[Evaluation and further development of a pyrogenicity assay based on human whole blood] (1998) (11)
[Development and evaluation of a pyrogen test based on human whole blood] (1998) (10)
Growth Factors G-CSF and GM-CSF: Clinical Options (2000) (10)
On the role of gamma-glutamyltransferase in renal tubular amino acid reabsorption. (1976) (10)
Ebselen--an in vivo immune response modifier. (1997) (10)
Do we need a "Chair of alternative methods", and where? (2002) (9)
Activation of an alternative death receptor-induced signaling pathway in human hepatocytes under caspase arrest. (2007) (9)
Sensitization by 5-Azacytidine toward Death Receptor-Induced Hepatic Apoptosis (2009) (9)
Fructose Protects Murine Hepatocytes from Tumor Necrosis Factor-induced Apoptosis by Modulating JNK Signaling* (2011) (9)
Differential immunotoxicity of histone deacetylase inhibitors on malignant and naïve hepatocytes. (2011) (9)
A novel xanthine derivative counteracting in vivo tumor necrosis factor alpha toxicity in mice. (1992) (9)
5-Oxoprolinase from rat kidney, I. Assay, purification, and determination of kinetic parameters. (1975) (8)
Malignant but not naïve hepatocytes of human and rodent origin are killed by TNF after metabolic depletion of ATP by fructose. (2010) (8)
[15-Hydroxyprostaglandin dehydrogenase from human placenta, II. Steady state kinetics and influence of prostaglandin F2alpha analogues (author's transl)]. (1975) (8)
[Glutathione biosynthesis. II. A kinetic approach to the reaction mechanism of glutathione synthetase (EC 6.3.2.3)]. (1972) (7)
GM-CSF counteracts hemorrhage-induced suppression of cytokine-producing capacity (2003) (7)
Increased proliferative activity in selenium-deficient mouse liver. (1986) (7)
Hydrocarbon exhalation. (1981) (6)
IN VITRO ASSESSMENT OF HEPATIC LIPID PEROXIDATION BY MALONDIALDEHYDE OR ETHANE DETERMINATION (1984) (6)
Tolerance against tumor necrosis factor alpha (TNF)-induced hepatotoxicity in mice: the role of nitric oxide. (1995) (6)
Overactivation of the Immune System by Translocated Bacteria and Bacterial Products. (1997) (6)
Protection by ebselen against endotoxin shock in rats or mice sensitized by galactosamine. (1987) (6)
Hepatic lipid peroxidation: caused by acute drug intoxication, prevented by liposomal glutathione. (1983) (6)
Initial Rate Kinetics of the Three-Substrate Reaction Catalyzed by Bovine Red-Cell Glutathione Synthetase (1975) (6)
The role of leukotriene D4 in septic shock models. (1992) (6)
The potential of GM-CSF to improve resistance against infections in organ transplantation. (2004) (6)
INTERACTION OF EBSELEN WITH HEPATIC ARACHIDONATE METABOLISM IN VIVO (1988) (6)
[Glutathione peroxidase. 3. Spectral characteristics and experiments for the reaction mechanism]. (1971) (5)
Molecular and kinetic properties of 15-hydroxyprostaglandin dehydrogenase (PG-15-HDH) from human placenta. (1976) (5)
Leukotrienes, Oxygen Radicals, and Cytokines in Septicemic Mice (1991) (5)
Reactive oxygen species, antiproteases, and cytokines in sepsis (1991) (5)
5-Oxoprolinase from rat kidney, II. Molecular weight determinations. (1975) (5)
[Biosynthesis of glutathione. VI. Ocurrence and level of gamma-glutamylcysteine in human red cells (author's transl)]. (1975) (5)
Se and Non-Se Glutathione Peroxidases: Enzymology and Cell Physiology (1982) (4)
Subcellular distribution of selenium in deficient mouse liver. (1989) (4)
Biological efficacy of partial hepatectomy and hepatopoietin in long-term selenium-deficient mice. (1987) (4)
Future trends of selenium in clinical applications. (1997) (4)
Solcoseryl prevents inflammatory and hypoxic but not toxic liver damage in rodents (1991) (4)
[I. Isolation and molecular weight determination of -L-glutamyl-L-cysteine: glycine ligase (EC 6.3.2.3)]. (1972) (4)
In-vivo inhibition by copper and some Cu-complexes of paracetamol-induced lipid peroxidation in benzpyrene-pretreated mice. (1980) (4)
Selenium-Dependent Metabolic Modulations in Mouse Liver (1989) (3)
[Activity of the glutathione redox system in human erythrocytes at various ages]. (1982) (3)
Biomarker Candidates of Chlamydophila pneumoniae Proteins and Protein Fragments Identified by Affinity-Proteomics Using FTICR-MS and LC-MS/MS (2011) (3)
Pharmacological Intervention Studies against Lipopolysaccharides or TNFα Toxicity in Mice (1993) (3)
[The significance of lipid peroxidation in drug-induced liver damage]. (1984) (3)
Montelukast exerts no acute direct effect on NO synthases. (2007) (3)
[Development of a pyrogen test based on rabbit blood] (1998) (2)
Isolation and characterization of rat primary lung cells (1995) (2)
Selective Protection of Human Liver Tissue in TNF-Targeting of Cancers of the Liver by Transient Depletion of Adenosine Triphosphate (2012) (2)
G‐CSF ‐ an anti‐inflammatory cytokine‐: 319 (1997) (2)
Potential of colony-stimulating factors to improve host defense in organ transplant recipients (2004) (2)
The Structure of the Selenoenzyme GSH Peroxidase (1981) (1)
[Is replacement of animal experimentation in pharmacology a goal or a social constraint, utopia or reality?] (1998) (1)
Liver Toxicity Mediated by Leukocytes and Kupffer Cells (1995) (1)
[The formation of a mediator of inflammation] (1996) (1)
[Does a modified gamma-glutamyl cycle exist in human erythrocytes (author's transl)]. (1976) (1)
Activation of Caspases in HepG2 Cells is Dispensable for Cytokine-mediated Apoptosis Induced by either TNF, TRAIL or Agonistic anti-CD95 Antibody (2004) (1)
[Development of a cell culture model for septic shock multiorgan failure] (1993) (1)
Filgrastim (r-metHuG-CSF) doubled CD4 counts in normal volunteers and restored in vitro IL-2 release in HIV patient blood (1997) (1)
23 – THE ROLE OF GLUTATHIONE AND ITS EICOSANOID ADDUCTS IN EXPERIMENTAL HEPATITIS IN MICE1 (1989) (1)
TERBUTALINE IMPROVES ISCHEMIA-REPERFUSION INJURY AFTER LEFT-SIDED ORTHOTOPIC RAT LUNG TRANSPLANTATION (2009) (1)
G-CSF, an anti-inflammatory cytokine: Its potential role in infectious disease (1997) (1)
NASH-induced release of ferritin-bound iron and allyl alkohol-induced lipid peroxidation in vivo (1990) (1)
Activation of Both TNF Receptors TNF Mediates Melphalan Hepatotoxicity via Kupffer Cell-Expressed Membrane-Bound (2005) (1)
PHOSPHOLIPID HYDROPEROXIDES ARE NOT SUBSTRATES FOR SELENIUMDEPENDENT GLUTATHIONE PEROXIDASE (1984) (1)
Short communication Redox control of hepatic cell death (2003) (0)
Diagnostic methods in biological system (1996) (0)
G-CSF TREATMENT OF NORMAL VOLUNTEERS INDUCES A SUSTAINED IMMUNOMODULATION CHARCTERIZED BY AN ANTI-INFLAMMATORY CYTOKINE RESPONSE: 172 (1999) (0)
LPS-induced tolerance in vivo is unrelated to endogenous TNF production (1991) (0)
Influences of Selenium Deficiency and Glutathione Status on Liver Metabolism (2019) (0)
Increased sensitivity of fatty liver against Cd95 induced apoptosis inleptin deficient Ob/Ob mice (2003) (0)
Novel pharmaceutical preparations as well as new compounds and their preparation lactosyl. (1988) (0)
Pyrogen-examination procedures (1995) (0)
Dichotomal function of GM‐CSF in experimental endotoxemia: 703 (1997) (0)
Kupffer cells and granulocytes synergize in endotoxin‐inducible hepatocytotoxicity.: 240 (1997) (0)
Specific therapeutic targeting of liver malignancies by transient depletion of adenosine tri-phosphates (2012) (0)
Procedure for diagnostic evaluation and control of the evolution of states of shock in humans as well as drugs for therapy. (1995) (0)
Thorax trauma-induced pulmonary oedema in rats ameliorated by terbutaline (2004) (0)
Abstract. Objective and design: To study whether a treat- ment with the hematopoietic growth factor GM-CSF restores the attenuated ex-vivo cytokine-producing capacity of macrophages after sublethal hemorrhagic shock. Subjects: Male Sprague-Dawley rats. Treatment: 20 mg/animal of recombinant murine G (0)
A link between reactive oxygen and cytokine release (1990) (0)
G-CSF and GM-CSF in the treatment of sepsis and inflammation (1998) (0)
[Permeability of the erythrocyte membrane to glutathione]. (1970) (0)
Infections C. pneumoniae with Persistent Antigens That Are Associated pneumoniae Chlamydia Serological Responses to Novel Immunoproteomic Identification and (2008) (0)
Tumor necrosis factor in bacterial and protozoan infections: to be or not to be? (2003) (0)
Differential sensitization of hepatocytes by inhibitors of histone deacetylases against death receptor-induced apoptosis (2006) (0)
Blood In Vitro Glucocorticoid-Immunosuppressed Human Immune Responses in GM-CSF Restores Innate , But Not Adaptive (2003) (0)
205 THE ANTI-INFLAMMATORY EFFECT OF G-CSF TREATMENT OF VOLUNTEERS ON BLOOD CYTOKINE RESPONSE (1995) (0)
On the interaction of G-CSF and TNF (1991) (0)
GM‐CSF as a potential treatment of sepsis‐related immunosuppression: 704 (1997) (0)
[Assay and normal levels of L-glutamate-L-cysteine-gamma-ligase (E.C. 6.3.2.2) in human erythrocytes; biosynthesis of glutathione V]. (1975) (0)
Mercaptan derivatives, processes for their preparation and pharmaceutical compositions containing them (1984) (0)
CYTOCHROME P-450-DEPENDENT AND -INDEPENDENT LIVER INJURY IN MICE (1991) (0)
Increase in cAMP e.g. by phosphodiesterase type 2‐inhibitors attenuates TNF‐inducible apoptosis in rat hepatocytes: 468 (1997) (0)
Use of frozen blood for biological testing procedures. (1997) (0)
New pharmaceutical preparations and new lactosyl and their preparation. (1988) (0)
RESCUE FROM SEVERE SEPTIC SHOCK BY G‐CSF: TWO CASE REPORTS: 152 (2004) (0)
Endogenous modulators of death receptor-mediated hepatic cell death (2002) (0)
Ebselen prevents the systemic endotoxin-induced release of TNFα and protects in vivo against TNF (1990) (0)
The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug (2007) (0)
TNF and angiostatin but not TGF-beta 1 are mediators endothelial cells in bronochoalveolar lavages of ARDS patients (2001) (0)
C31. Preventive effect of selenium on cytotoxicity in oxidant treated J774.1 macrophages cell line (2007) (0)
Role of Protein Kinase C‐alpha in Listeriolysin‐induced ENaC dysfunction in human airway epithelial cells (2011) (0)
Mercaptanderivater, process for their preparation and pharmaceutical compositions containing same (1985) (0)
Antioxidant intervention studies in cytochrome P450-dependent and P450-independent mouse liver injury models (1990) (0)
Phorone prevents CD95-mediated fulminant liver injury in vivo via attenuation of caspase activation (1998) (0)
Tumor Necrosis Factor Production in the Perfused Mouse Liver and Its Pharmacological Modulation by Methylxanthines 1 , 2 (2003) (0)
The lectin‐like domain of TNF blunts LLO‐mediated suppression of SGK1 activity and hyperpermeability in human airway H441 cells (2009) (0)
Method for the diagnostic assessment and monitoring and drugs for the treatment of shock in humans (1994) (0)
Specific therapeutic targeting of malignancies of the liver by transient depletion of adenosine triphosphates (2011) (0)
[Kinetics of glutathione synthetase]. (1972) (0)
Fructose metabolism in hepatocytes: primary cells or cell lines? (2007) (0)
Activation of alternative apoptosis pathways in HepG2 cells after caspase arrest (2006) (0)
Endotoxin and muropeptides from E. coli synergize in cytokine induction in human whole blood: 96 (1997) (0)
Sensitization of hepatocytes by methyltransferase-inhibitor 5-azacytidine against cytokine-mediated cell death (2007) (0)
(641) - Evaluation of Thalidomide in Left Ventricular Assist Device Associated Gastrointestinal Bleeding (2017) (0)
Ex Vivo Pulmonary Oedema after In Vivo Blast-Induced Rat Lung Injury: Time Dependency, Blast Intensity and Beta-2 Adrenergic Receptor Role (2022) (0)
Ethane production of isolated perfused rat liver (0)
Characteristics of inflammatory response and repair after experimental blast lung injury in rats (2023) (0)
Phosphodiesterase inhibitors suppress tumor necrosis factor release and protect mice from T-cell-dependent liver failure (1996) (0)
Sensitization to endotoxin by GM‐CSF: 706 (1997) (0)
[The biosynthesis of glutathione in human erythrocytes (author's transl)]. (1976) (0)
An In Vitro Model of Hepatic Failure in Septic Shock (1993) (0)
The diagnostic dilemma of covid-19 pneumonia in a kidney transplant patient-a case report (2020) (0)
Attenuation of the inflammatory response by cytokines: 305 (1997) (0)
Tolerance phenomena in lps induced hepatocytotoxicity in vitro (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Albrecht Wendel?

Albrecht Wendel is affiliated with the following schools:

Albrecht Wendel's Academic­Influence.com Rankings

Albrecht Wendel's Degrees

Why Is Albrecht Wendel Influential?

Albrecht Wendel's Published Works

Published Works

What Schools Are Affiliated With Albrecht Wendel?

Albrecht Wendel's AcademicInfluence.com Rankings